Therapeutics
Other Neurotransmitters
- Study completed / Planned end date
- Planned end date unavailable
- Study aborted
| Other Neurotransmitters | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BI 409306 |
Phase 2
|
||||||||||||||
| BI 425809 |
Phase 2
|
||||||||||||||
| Brexpiprazole |
Phase 3
|
||||||||||||||
| Dexpramipexole |
Phase 2
|
||||||||||||||
| Guanfacine |
Phase 3
|
||||||||||||||
| Idalopirdine |
Phase 2, Phase 3
|
||||||||||||||
| Intepirdine |
Phase 2, Phase 3
|
||||||||||||||
| Masupirdine |
Phase 2
|
||||||||||||||
| ORM-12741 |
Phase 2
|
||||||||||||||
| PF-05212377 |
Phase 2
|
||||||||||||||
| Piromelatine |
Phase 2
|
||||||||||||||
| Riluzole |
Phase 2
|
||||||||||||||
| VY-AADC |
Phase 1
|